Aurinia Pharmaceuticals Inc.

NasdaqGM:AUPH Stock Report

Mkt Cap: US$1.3b

Aurinia Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:AUPH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Nov 22BuyUS$46,600Matthew DonleyIndividual10,000US$4.66
09 Nov 22BuyUS$25,075Scott HabigIndividual5,000US$5.02
07 Nov 22BuyUS$154,800Michael MartinIndividual30,000US$5.16
09 Mar 22BuyUS$54,985R. Mackay-DunnIndividual5,000US$11.00
04 Mar 22BuyUS$54,100George MilneIndividual5,000US$10.82
02 Mar 22SellUS$58,236Robert HuizingaIndividual4,849US$12.01
02 Mar 22SellUS$58,200Neil SolomonsIndividual4,846US$12.01
02 Mar 22SellUS$38,492Massimiliano ColaoIndividual3,205US$12.01
02 Mar 22SellUS$58,236Michael MartinIndividual4,849US$12.01
02 Mar 22SellUS$108,907Peter GreenleafIndividual9,068US$12.01
02 Mar 22SellUS$36,751Joseph MillerIndividual3,060US$12.01
02 Mar 22SellUS$36,655Matthew DonleyIndividual3,052US$12.01
28 Feb 22BuyUS$2,350,000ILJIN SNT Co., LtdCompany200,000US$11.75

Insider Trading Volume

Insider Buying: AUPH insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AUPH?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,123,6080.8%
Individual Insiders1,914,6051.3%
VC/PE Firms7,841,5705.5%
Institutions56,428,60639.7%
General Public74,801,31452.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.6%.


Top Shareholders

Top 25 shareholders own 38.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.52%
Deep Track Capital, LP
7,841,570$72.2m38.12%2.42%
5.43%
BlackRock, Inc.
7,713,055$71.0m-1.26%no data
4.26%
ILJIN SNT Co., Ltd
6,060,290$55.8m6.16%no data
3.51%
FMR LLC
4,994,605$46.0m2.15%no data
2.79%
New Enterprise Associates, Inc.
3,969,834$36.6m0%1.39%
2%
Bellevue Asset Management AG
2,846,457$26.2m6.55%0.24%
1.94%
Citadel Advisors LLC
2,750,116$25.3m216.38%0.03%
1.72%
State Street Global Advisors, Inc.
2,441,434$22.5m2.24%no data
1.02%
Morgan Stanley, Investment Banking and Brokerage Investments
1,443,163$13.3m-49.57%no data
0.85%
The Vanguard Group, Inc.
1,207,609$11.1m3.31%no data
0.85%
Geode Capital Management, LLC
1,204,982$11.1m3.56%no data
0.79%
ILJIN Holdings Co., Ltd.
1,123,608$10.3m0%no data
0.75%
Rock Springs Capital Management LP
1,066,408$9.8m30.83%0.21%
0.71%
Northern Trust Global Investments
1,004,868$9.3m-1.42%no data
0.7%
Artal Group S.A.
1,000,000$9.2m0%0.42%
0.68%
Stifel Asset Management Corp.
967,931$8.9m-7.07%0.01%
0.6%
Balyasny Asset Management L.P.
853,787$7.9m71.01%0.03%
0.6%
Citigroup Inc.,Banking and Securities Investments
850,680$7.8m-1.28%0.01%
0.55%
Susquehanna International Group, LLP, Asset Management Arm
776,381$7.2m-54.78%0.01%
0.52%
Renaissance Technologies LLC
733,800$6.8m22.59%0.01%
0.51%
Armistice Capital, LLC
724,000$6.7m0%0.12%
0.51%
Kyoung Huh Sae
722,740$6.7m0%no data
0.51%
Eun Huh Seoung
722,740$6.7m0%no data
0.44%
Barclays PLC Private Banking & Investment Banking Investment
630,250$5.8m-38.42%0.01%
0.4%
SV Health Investors, LLC
573,530$5.3m0%1.15%